{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:39:23Z","timestamp":1793417963419,"version":"4.5.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Abnormal expression levels of microRNAs (miRNAs) were observed in ankylosing spondylitis (AS) in recent articles, suggesting that miRNAs may be used as biomarkers for AS diagnoses. In this paper, we conducted a meta-analysis to identify the overall diagnostic accuracy of miRNA biomarkers in AS patients.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> An extensive search was undertaken in PubMed, Embase, Cochrane databases, and Wan Fang database up to 30 December 2020 using the following key words: (\u201cmicroRNAs\u201d or \u201cmicroRNA\u201d or \u201cmiRNA\u201d or \u201cmiR\u201d or \u201cRNA, Micro\u201d or \u201cPrimary MicroRNA\u201d) and (\u201cSpondylitis Ankylosing\u201d or \u201cSpondyloarthritis Ankylopoietica\u201d or \u201cAnkylosing Spondylarthritis\u201d or \u201cAnkylosing Spondylarthritides\u201d or \u201cSpondylarthritides Ankylosing\u201d or \u201cAnkylosing Spondylitis\u201d) and (\u201cblood\u201d or \u201cserum\u201d or \u201cplasma\u201d). Statistical evaluation of dysregulated miRNAs using the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and the area under the curve (AUC).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Twenty-nine articles reporting on the miRNAs of AS were included. A total of 42 miRNAs were observed to be up-regulated and 45 miRNAs were down-regulated in the AS cases compared with the controls. Besides, 29 studies from nine articles were included in our meta-analysis. The pooled sensitivity, specificity, PLR, NLR, DOR, and AUC were 0. 76 (95% CI, 0.70\u20130.81), 0.80 (95% CI, 0.74\u20130.85), 3.75 (95% CI, 2.82\u20135.01), 0.30 (95% CI, 0.24\u20130.39), 12.32 (95% CI, 7.65\u201319.83), 0.85 (95% CI, 0.81\u20130.88), respectively, suggesting a good diagnostic accuracy of miRNAs for AS.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Circulating miRNAs are deregulated in AS patients. miRNAs may be used as a relatively non-invasive biomarkers for the detection of AS.<\/jats:p>","DOI":"10.3389\/fmed.2021.701789","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T06:32:36Z","timestamp":1628577156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["MicroRNAs as Biomarkers for the Diagnosis of Ankylosing Spondylitis: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"8","author":[{"given":"Jiangbi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangqiang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjiang","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiecheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3899\/jrheum.130515","article-title":"Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration","volume":"41","author":"Huang","year":"2014","journal-title":"J Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology (Oxford)."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7146","DOI":"10.1038\/ncomms8146","article-title":"Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1","volume":"6","author":"Cortes","year":"2015","journal-title":"Nat Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","article-title":"Spondyloarthritis","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/1529-0131(199803)41:3<460::AID-ART12>3.0.CO;2-X","article-title":"The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis","volume":"41","author":"Brown","year":"1998","journal-title":"Arthritis Rheum."},{"key":"B6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/annrheumdis-2018-213779","article-title":"HLA class I and II alleles in susceptibility to ankylosing spondylitis","volume":"78","author":"Reveille","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1136\/annrheumdis-2013-203352","article-title":"MICA, a gene contributing strong susceptibility to ankylosing spondylitis","volume":"73","author":"Zhou","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/annrheumdis-2018-214625","article-title":"Genetic association of non-MHC region with ankylosing spondylitis in a Chinese population","volume":"78","author":"Liu","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0122055","DOI":"10.1371\/journal.pone.0122055","article-title":"Association between ankylosing spondylitis and the miR-146a and miR-499 polymorphisms","volume":"10","author":"Xu","year":"2015","journal-title":"PLoS One."},{"key":"B10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13105-010-0050-6","article-title":"Biological functions of microRNAs: a review","volume":"67","author":"Huang","year":"2011","journal-title":"J Physiol Biochem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","article-title":"MicroRNAs in stress signaling and human disease","volume":"148","author":"Mendell","year":"2012","journal-title":"Cell."},{"key":"B12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10238-016-0422-5","article-title":"Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis","volume":"17","author":"Wang","year":"2017","journal-title":"Clin Exp Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1007\/s12035-014-8822-6","article-title":"MicroRNAs as potential biomarkers for diagnosing cancers of central nervous system: a meta-analysis","volume":"51","author":"Wei","year":"2015","journal-title":"Mol Neurobiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/bjc.2017.12","article-title":"Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis","volume":"116","author":"Carter","year":"2017","journal-title":"Br J Cancer."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1111\/cas.13714","article-title":"MicroRNAs as potential biomarkers for the diagnosis of glioma: a systematic review and meta-analysis","volume":"109","author":"Zhou","year":"2018","journal-title":"Cancer Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"h15","DOI":"10.1136\/bmj.h15","article-title":"Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis","volume":"350","author":"Zhelev","year":"2015","journal-title":"BMJ."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/rheumatology\/kez594","article-title":"miR-214 stimulated by IL-17A regulates bone loss in patients with ankylosing spondylitis","volume":"59","author":"Liu","year":"2020","journal-title":"Rheumatology (Oxford)."},{"key":"B18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s10020-020-00157-3","article-title":"Down-regulated miR-495 can target programmed cell death 10 in ankylosing spondylitis","volume":"26","author":"Ni","year":"2020","journal-title":"Mol Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/hmg\/ddy008","article-title":"Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients","volume":"27","author":"Perez-Sanchez","year":"2018","journal-title":"Hum Mol Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/1756-185X.13563","article-title":"Aberrant expression of microRNAs in peripheral blood mononuclear cells as candidate biomarkers in patients with axial spondyloarthritis","volume":"22","author":"Li","year":"2019","journal-title":"Int J Rheum Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s10067-018-4017-2","article-title":"Predictive value of microRNA-132 and its target gene NAG-1 in evaluating therapeutic efficacy of non-steroidal anti-inflammatory drugs treatment in patients with ankylosing spondylitis","volume":"37","author":"Guo","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B22","first-page":"2701","article-title":"Expression and clinical significance of miR-17 and MMP-3 in patients with ankylosing spondylitis","volume":"28","author":"Jiang","year":"2018","journal-title":"Chin J Health Lab Tec."},{"key":"B23","first-page":"766","article-title":"miR-146a, miR-155, miR-181a and miR-223 level differences in peripheral blood of patients with ankylosing spondylitis","volume":"36","author":"Jiang","year":"2018","journal-title":"Exp Lab Med."},{"key":"B24","author":"Liu","year":"2015","journal-title":"Detection the Expression Levels of Five Kinds of MicroRNAs in Ankylosing Spondylitis Patients' Peripheral Blood Mononuclear Cells and the Regulatory Effect of miR 495 on DVL-2 Protein"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2180913","DOI":"10.1155\/2020\/2180913","article-title":"miRNA-451a and miRNA-125a expression levels in ankylosing spondylitis: impact on disease diagnosis, prognosis, and outcomes","volume":"2020","author":"Fotoh","year":"2020","journal-title":"J Immunol Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5606\/ArchRheumatol.2016.5733","article-title":"Micro-ribonucleic acid profiles from microarray in ankylosing spondylitis","volume":"31","author":"Jin","year":"2016","journal-title":"Arch Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2478\/bjmg-2020-0006","article-title":"The expression levels of microRNAs associated with T and B cell differentiation\/stimulation in ankylosing spondylitis","volume":"23","author":"Turkyilmaz","year":"2020","journal-title":"Balkan J Med Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.12659\/MSM.905238","article-title":"Overexpression of miR-31 in peripheral blood mononuclear cells (PBMC) from patients with ankylosing spondylitis","volume":"23","author":"Wang","year":"2017","journal-title":"Med Sci Monit."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.3892\/etm.2017.5155","article-title":"Correlation of the expression of miR-146a in peripheral blood mononuclear cells of patients with ankylosing spondylitis and inflammatory factors","volume":"14","author":"Wei","year":"2017","journal-title":"Exp Ther Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3109\/14397595.2013.854077","article-title":"Elevated miR-29a expression is not correlated with disease activity index in PBMCs of patients with ankylosing spondylitis","volume":"24","author":"Huang","year":"2014","journal-title":"Mod Rheumatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3109\/14397595.2015.1023887","article-title":"MicroRNA-124 involves in ankylosing spondylitis by targeting ANTXR2","volume":"25","author":"Xia","year":"2015","journal-title":"Mod Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3892\/mmr.2015.4494","article-title":"Role of histone deacetylase 3 in ankylosing spondylitis via negative feedback loop with microRNA-130a and enhancement of tumor necrosis factor-1alpha expression in peripheral blood mononuclear cells","volume":"13","author":"Jiang","year":"2016","journal-title":"Mol Med Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/BRS.0000000000001339","article-title":"Identification of serum miR-146a and miR-155 as novel noninvasive complementary biomarkers for ankylosing spondylitis","volume":"41","author":"Qian","year":"2016","journal-title":"Spine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.26355\/eurrev_201808_15704","article-title":"Expression and function of peripheral blood miRNA16a in patients with ankylosing spondylitis","volume":"22","author":"Zhang","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00005-018-0513-y","article-title":"Changes in MiRNA-5196 expression as a potential biomarker of anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis patients","volume":"66","author":"Ciechomska","year":"2018","journal-title":"Arch Immunol Ther Exp (Warsz)."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s10067-019-04509-1","article-title":"Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naive to anti-TNF therapy","volume":"38","author":"Reyes-Loyola","year":"2019","journal-title":"Clin Rheumatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cei.12089","article-title":"Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis","volume":"173","author":"Lai","year":"2013","journal-title":"Clin Exp Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"504208","DOI":"10.1155\/2015\/504208","article-title":"Disorders of microRNAs in peripheral blood mononuclear cells: as novel biomarkers of ankylosing spondylitis and provocative therapeutic targets","volume":"2015","author":"Lv","year":"2015","journal-title":"Biomed Res Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1159\/000480211","article-title":"MicroRNA-199a-5p induced autophagy and inhibits the pathogenesis of ankylosing spondylitis by modulating the mTOR signaling via directly targeting ras homolog enriched in brain (Rheb)","volume":"42","author":"Wang","year":"2017","journal-title":"Cell Physiol Biochem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/1756-185X.13475","article-title":"Serum miR-214 as a novel biomarker for ankylosing spondylitis","volume":"22","author":"Kook","year":"2019","journal-title":"Int J Rheum Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s10067-015-3123-7","article-title":"Identification of plasma microRNA expression profile in radiographic axial spondyloarthritis-a pilot study","volume":"35","author":"Magrey","year":"2016","journal-title":"Clin Rheumatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0185323","DOI":"10.1371\/journal.pone.0185323","article-title":"Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis","volume":"12","author":"Prajzlerova","year":"2017","journal-title":"PLoS One."},{"key":"B43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5114\/ceji.2019.84018","article-title":"Altered expression of microRNAs targeting Dkk-1 in peripheral blood mononuclear cells of patients with ankylosing spondylitis","volume":"44","author":"Huang","year":"2019","journal-title":"Cent Eur J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"100574","DOI":"10.1016\/j.genrep.2019.100574","article-title":"Oxidative stress and immunological biomarkers in Ankylosing spondylitis patients","volume":"18","author":"Danaii","year":"2019","journal-title":"Gene Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","article-title":"Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis","volume":"23","author":"Feldtkeller","year":"2003","journal-title":"Rheumatol Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11926-019-0819-8","article-title":"The European map of axial spondyloarthritis: capturing the patient perspective-an analysis of 2846 patients across 13 countries","volume":"21","author":"Garrido-Cumbrera","year":"2019","journal-title":"Curr Rheumatol Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41584-020-0450-0","article-title":"Biomarker development for axial spondyloarthritis","volume":"16","author":"Brown","year":"2020","journal-title":"Nat Rev Rheumatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA."},{"key":"B49","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrrheum.2010.81","article-title":"MicroRNAs as biomarkers in rheumatic diseases","volume":"6","author":"Alevizos","year":"2010","journal-title":"Nat Rev Rheumatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1002\/jcp.26500","article-title":"MicroRNA implicationsin the etiopathogenesis of ankylosing spondylitis","volume":"233","author":"Mohammadi","year":"2018","journal-title":"J Cell Physiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1038\/emm.2017.288","article-title":"Evaluation of several methodological challenges in circulating miRNA qPCR studies in patients with head and neck cancer","volume":"50","author":"Poel","year":"2018","journal-title":"Exp Mol Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1007\/s00018-012-1124-0","article-title":"MicroRNA-29 in the adaptive immune system: setting the threshold","volume":"69","author":"Liston","year":"2012","journal-title":"Cell Mol Life Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"25221","DOI":"10.1074\/jbc.M110.116137","article-title":"miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop","volume":"285","author":"Kapinas","year":"2010","journal-title":"J Biol Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/ard.2003.011247","article-title":"How to diagnose axial spondyloarthritis early","volume":"63","author":"Rudwaleit","year":"2004","journal-title":"Ann Rheum Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.701789\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T06:32:41Z","timestamp":1628577161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.701789\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":54,"alternative-id":["10.3389\/fmed.2021.701789"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.701789","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"article-number":"701789"}}